Skip to main content
Veterinary Medicines

Frontline Spot on Hund L 268 mg Lösung zum Auftropfen auf die Haut für Hunde

Authorised
  • Fipronil

Product identification

Medicine name:
Frontline Spot on Hund L 268 mg Lösung zum Auftropfen auf die Haut für Hunde
Active substance:
  • Fipronil
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Fipronil
    268.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX15
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00349
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 25/05/2023
Updated on: 4/02/2025

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 25/05/2023
Updated on: 4/02/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 25/05/2023
Updated on: 4/02/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."